iRhythm Quarterly Cash Flow Statement
NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRhythm free cash flow
In the quarter ended Jun 30, 2026, iRhythm generated $51.1 million of operating cash flow and spent $13.6 million on capital expenditures. That left free cash flow of $37.5 million, a free-cash-flow margin of 16.7% of revenue. Free cash flow was up 117.0% from the prior year's $17.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
iRhythm cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -381.00K | -13.93M | 5.58M | -5.21M | -14.22M | -30.70M | -1.33M | -46.18M | -20.11M | -45.67M | -38.70M | -27.12M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 5.20M | 5.00M | 5.20M | 5.20M | 5.10M | 5.20M | 5.30M | 5.10M | 5.20M | 5.10M | 4.90M | 4.10M |
| Stock-Based Compensation | 20.04M | 21.49M | 21.11M | 21.01M | 22.83M | 23.34M | 16.01M | 17.16M | 21.82M | 20.99M | 23.85M | 21.01M |
| Change in Working Capital | 2.00M | -62.70M | -25.35M | -6.85M | -12.99M | -34.82M | -24.41M | -4.87M | -14.60M | -50.74M | -24.75M | 12.03M |
| Operating Cash Flow | 51.08M | -26.17M | 26.21M | 34.88M | 27.66M | -7.89M | 19.23M | 24.35M | 11.84M | -52.03M | -15.97M | 1.20M |
| Capital Expenditures | -13.56M | -6.91M | -11.72M | -14.83M | -10.37M | -9.42M | -6.84M | -8.83M | -8.49M | -9.78M | -13.52M | -9.09M |
| Investing Cash Flow | -48.64M | 30.21M | -48.80M | -89.20M | -100.92M | -38.14M | -122.16M | -55.33M | 14.51M | 40.00M | 1.40M | -15.44M |
| Share Repurchases | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.00M | 0 | 0 |
| Debt Issued | — | — | — | — | — | — | — | — | 0 | 75.00M | 0 | 0 |
| Debt Repaid | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | 4.08M | 149.00K | 2.96M | 825.00K | 7.09M | 1.73M | 2.99M | -35.00K | 3.79M | 504.64M | 3.47M | 66.00K |
| Net Change in Cash | 6.53M | 4.13M | -19.59M | -53.50M | -66.17M | -44.32M | -99.94M | -31.02M | 30.13M | 492.61M | -11.30M | -14.10M |
| Free Cash Flow | 37.52M | -33.08M | 14.49M | 20.05M | 17.29M | -17.31M | 12.39M | 15.51M | 3.35M | -61.80M | -29.49M | -7.89M |
This table shows 12 quarterly periods of iRhythm's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRTC's reporting calendar. What is a cash flow statement?